Author:
Schwartsmann G.,van der Vijgh W.J.F.,van Hennik M.B.,Klein I.,Vermorken J.B.,Dodion P.,ten Bokkel Huinink W.W.,Joggi G.,Gall H.,Crespeigne N.,Simonetti G.,Winograd B.,Pinedo H.M.
Reference15 articles.
1. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt] against experimental tumors;Dexter;Cancer Res,1985
2. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis;Chen;Cancer Res,1986
3. Application of a new preclinical drug screening system for cancer of the large bowel;Scheithauer;Cancer Chemother Pharmacol,1988
4. Inhibition of pyrimidine de novo synthesis by DUP 785 (NSC 368390);Peters;Invest New Drugs,1987
5. DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects;Schwartsmann;Biochem Pharmacol,1988
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献